Xiaodong Wang, Director at BeOne Medicines Ltd. (ONC), sold 38,287 shares at $345.38 ($13.4M) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Scheduled sale ($13.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $345.38 | 1,181 | $408K | 3.1% |
| 2 | $346.16 | 2,841 | $983K | 7.4% |
| 3 | $347.39 | 1,517 | $527K | 3.9% |
| 4 | $348.01 | 1,721 | $599K | 4.5% |
| 5 | $348.31 | 7,492 | $2.6M | 19.5% |
| 6 | $349.28 | 10,688 |
| $3.7M |
| 27.9% |
| 7 | $350.27 | 6,569 | $2.3M | 17.2% |
| 8 | $351.25 | 6,278 | $2.2M | 16.5% |
| Total | $349.10 avg | 38,287 | $13.4M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |